Immix Biopharma, Inc. (IMMX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -9.83M | -11.03M | -5.91M | -5.31M | -1.69M | -1.48M | -4.04M | -5.26M | -3.83M | -2.68M | -3.09M | -3.52M | -2.09M | -3.9M | -1.46M | -547.07K | -1.49M | -1.11M | -50.76K | -158.01K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -483.17% | -647.16% | -46.32% | -1.02% | 55.97% | 44.87% | -30.76% | -49.52% | -82.93% | 31.42% | -111.06% | -542.58% | -39.95% | -250.41% | -2781.24% | -246.23% | -461.02% | -800.98% | - | - |
| Net Income | -10.09M | -10.69M | -7.59M | -6.62M | -4.54M | -4.81M | -7.15M | -4.41M | -5.33M | -5.16M | -4.28M | -3.6M | -2.5M | -3.8M | -1.54M | -1.56M | -1.33M | -22.76M | -403.26K | -208.64K |
| Depreciation & Amortization | 130.77K | 90.63K | 134.85K | 79.83K | 59.18K | 41.34K | 25.91K | 24.3K | 23.85K | 3.08K | 1.38K | 506 | 505 | 566 | 566 | 383 | 620 | 620 | 620 | 20.35K |
| Stock-Based Compensation | 575.57K | 570.8K | 470.47K | 532.25K | 868.36K | 705.65K | 733.81K | 637.85K | 943.26K | 1.05M | 0 | 447.66K | 329.92K | 230.09K | 213.19K | 115.71K | 65.07K | 122.15K | 61.86K | 30.72K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 23.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 674.08K | 0 | 0 | 0 | 0 | 0 | 0 | 22.13M | 20.12K | -40.79K |
| Working Capital Changes | -470.34K | -1M | 1.07M | 700.7K | 1.93M | 2.59M | 2.35M | -1.51M | 537.1K | 1.42M | 518.55K | -365.3K | 75.61K | -334.75K | -141.2K | 899.62K | -228.47K | -609.16K | 269.9K | 40.35K |
| Change in Receivables | -725 | 12.38K | 21.56K | 21.98K | 2M | -224.78K | 68.54K | 96.25K | -911.54K | -465.93K | -380.24K | 24.95K | -72.19K | -60.95K | -29.26K | -110.22K | -35.96K | 170.6K | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 432.21K | -790.86K | 0 | 0 | 0 | 2.28M | 0 | 0 | 0 | 854.22K | 451.96K | 937.49K | 190.81K | 624.79K | -330.54K | 676.56K | 160.93K | -306.89K | 267.47K | 0 |
| Cash from Investing | -4.8M | -6.65M | -372.46K | -127.63K | -67.71K | -507.15K | -271.54K | -97.07K | -301.91K | -13.18K | -38.91K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | -32.49K | -165.13K | -372.46K | -127.63K | -67.71K | -507.15K | -271.54K | -97.07K | -301.91K | -13.18K | -38.91K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -37.56K | 95.67M | 10.61M | 1.11M | 0 | 0 | 0 | 0 | 15.95M | 586.69K | 10.07M | 4.69M | 118.92K | 424.28K | 0 | -105.96K | 2.91M | 18.72M | -18.35K | 82.33K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50K | 0 | 0 | 0 | 100K |
| Equity Issued (Net) | -37.56K | 95.67M | 10.77M | 1.1M | 0 | 0 | 0 | 0 | 15.95M | 584.07K | 10.07M | 4.88M | 103.92K | -44K | 0 | -55.96K | 2.91M | 18.72M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -44K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -166.24K | 5.82K | 0 | 0 | 0 | 0 | 2.49K | 2.62K | 0 | -190.82K | 15K | 468.28K | 0 | 0 | 0 | 0 | -18.35K | -17.67K |
| Net Change in Cash | -14.68M | 77.98M | 4.31M | -4.28M | -1.76M | -2.01M | -4.28M | -5.34M | 11.81M | -2.07M | 6.93M | 1.19M | -1.97M | -3.48M | -1.49M | -658.33K | 1.42M | 17.61M | -72.61K | -70.19K |
| Free Cash Flow | -9.86M | -11.19M | -6.28M | -5.44M | -1.75M | -1.98M | -4.31M | -5.35M | -4.13M | -2.69M | -3.13M | -3.52M | -2.09M | -3.9M | -1.46M | -547.07K | -1.49M | -1.11M | -50.76K | -158.01K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -462.49% | -464.44% | -45.75% | -1.58% | 57.55% | 26.29% | -37.82% | -52.28% | -97.36% | 31.08% | -113.72% | -542.58% | -39.95% | -250.41% | -2781.24% | -246.23% | -459.34% | -800.98% | - | - |
| FCF per Share | -0.26 | -0.29 | -0.20 | -0.18 | -0.06 | -0.07 | -0.15 | -0.19 | -0.18 | -0.14 | -0.17 | -0.23 | -0.15 | -0.30 | -0.11 | -0.04 | -0.11 | -0.15 | -0.01 | -0.02 |
| FCF Conversion (FCF/Net Income) | 0.97x | 1.03x | 0.78x | 0.80x | 0.37x | 0.31x | 0.56x | 1.20x | 0.73x | 0.53x | 0.72x | 0.98x | 0.84x | 1.03x | 0.95x | 0.35x | 1.12x | 0.05x | 0.13x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.52K | 80 | 0 | 0 | 63 |
| Taxes Paid | 0 | 0 | 7.72K | 8.91K | 9.82K | 0 | 11.14K | 10.27K | 8.84K | -18.33K | 0 | 6.35K | 5.17K | 0 | 0 | -1.62K | 1.62K | 0 | 0 | 0 |